Download PDF
Thromb Haemost 2008; 99(05): 801-802
DOI: 10.1160/TH08-03-0192
Editorial Focus
Schattauer GmbH

Thromboembolic complications of sepsis: What is the incidence and pathophysiological mechanisms involved?

Michal Holub
1   3rd Department of Infectious and Tropical Diseases, First Faculty of Medicine, Charles University in Prague, Czech Republic
› Author Affiliations
Further Information

Publication History

Received 28 March 2008

Accepted 28 March 2008

Publication Date:
30 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Levine R, LeClerc J, Bailey J. et al. Venous and arterial thromboembolism in severe sepsis. Thromb Haemost 2008; 99: 892-898.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Cade JF. High risk of the critically ill for venous thromboembolism. Crit Care Med 1981; 10: 448-450.
    PubMedGoogle Scholar
  • 3 Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. J Am Med Assoc 1995; 274: 335-337.
    CrossrefPubMedGoogle Scholar
  • 4 Samama MM, Cohen AT, Darmon JY. et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800.
    CrossrefPubMedGoogle Scholar
  • 5 Bernard GR, Vincent JL, Laterre PF. et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
    CrossrefPubMedGoogle Scholar
  • 6 Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1-41.
    CrossrefPubMedGoogle Scholar
  • 7 Zenahlikova Z, Vyborny J, Uchytil Z. et al. Thromboembolic complications of sepsis and their pharmacological prophylaxis. Cas Lek Ces 2007; 146: 597-602.
    PubMedGoogle Scholar
  • 8 Dellinger RP, Carlet JM, Masur H. et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30: 536-555.
    CrossrefPubMedGoogle Scholar
  • 9 Geerts WH, Pineo GF, Heit JA. et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (Suppl. 03) 338S-400S.
    CrossrefPubMedGoogle Scholar
  • 10 Rutherford EJ, Schooler WG, Sredzienski E. et al. Optimal dose of enoxaparin in critically ill trauma and surgical patiens. J Trauma 2005; 58: 1167-1170.
    CrossrefPubMedGoogle Scholar
  • 11 Hamm CW, Giannitis E. Katus EI et al. Cardiac troponin elevation in patiens without acute coronary syndrome. Circulation 2002; 106: 2871-2872.
    CrossrefPubMedGoogle Scholar
  • 12 Gurkan F, Alkaya A, Ece A. et al. Cardiac troponin-I as a marker of myocardial dysfunction in children with septic shock. Weiss Med Wkly 2004; 134: 593-596.
    PubMedGoogle Scholar
  • 13 Sharshar T, Carlier R, Bernard F. et al. Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med 2007; 33: 798-806.
    CrossrefPubMedGoogle Scholar